“What changes will artificial intelligence (AI) in the field of biotechnology bring to our lives in the future?”

Andrew Radin, head of StartX at Stanford University, began his keynote speech with this question on the 22nd at the 'G-BIO WEEK X AI CONNECT with G-FAIR 2025' held at the Suwon Convention Center in Gyeonggi Province.

In his lecture on 'The Present and Future of AI-Based Life Science Innovation,' he stated, “Image analysis and large-scale screening used to analyze complex patient data to detect difficult-to-diagnose diseases and pathogens are representative cases where AI diagnostic technology becomes the foundation for new drug development,” and predicted, “Korean companies like SK Biopharmaceuticals will actively adopt AI to create new growth opportunities.”

● Bio and AI Convergence as Future Strategic Industries

‘G-BIO WEEK X AI CONNECT with G-FAIR 2025’ was held for three days from the 22nd to the 24th at the Suwon Convention Center. This event was organized to create an innovative ecosystem where technology, industry, and policy are interconnected by combining the bio and AI fields, which Gyeonggi Province is nurturing as future strategic industries. It was co-hosted by Gyeonggi Province and Suwon City, and organized by the Gyeonggi-do Economic Science Promotion Agency (Gyeonggawon) and Suwon Convention Center, attracting more than 4,000 business people, researchers, and general citizens over the three days.

On site, various specialized meetings such as the 'Gwanggyo Quantum Bio Summit,' 'Gwanggyo Bio-Health Forum,' and 'AI Forum' were held. The 'G-FAIR AI Export Exhibition' included corporate investment and export consultations, presentations on new bio and AI technologies, and experiential events for the general public.

At the Gwanggyo Bio-Health Forum, discussions were held on the convergence of the bio-health industry and AI, next-generation new drug development, and ways to create an industrial ecosystem, combining technology and policy. Kim Jae-eun, CEO of First Bio Therapeutics Co., Ltd., said, “By directly confirming domestic and international AI utilization cases, I was able to reassess our company's research and development direction,” and added, “We plan to actively pursue joint research collaborations with overseas companies met on site.”

On the 'AI Connect Forum' stage, demonstrations that captivated participants' attention were held. Programming YouTuber Joco Coding demonstrated the process of creating Gyeonggi mascot character content using ChatGPT and the image generation AI model Midjourney, filling the venue with cheers and laughter. University student Kim Seong-jun (22) expressed, “I thought AI was a vague future technology, but the learning methods and employment strategies I heard in the lecture were realistic,” and added, “I want to apply them immediately.”

● Achievements of Gyeonggi AI Companies in Overseas Expansion

At this event, the 'G-FAIR AI Export Exhibition,' in which 25 AI companies from Gyeonggi Province participated, was also held. Participating companies, including AI Healthcare Group Moa Co., Ltd., conducted consultations with 37 overseas buyers from countries such as the United States and China, resulting in contracts worth a total of USD 14.49 million.

A company from Suwon City showcased a 'smart mirror' that combines AI-based skin diagnosis technology and personalized cosmetic recommendation functions, signing a business agreement with T Company, a U.S. beauty device specialist. Citizens who had their skin condition diagnosed on site showed interest, saying, “The personalized cosmetics recommended by AI perfectly match my actual skin concerns.”

Gyeonggi Province and Gyeonggawon plan to continuously support bio and AI convergence research and new technology development based on the global network established at this event. Kim Hyun-gon, Director of Gyeonggawon, emphasized, “We will create an innovative ecosystem where companies and research institutions work together to demonstrate clear leadership in the bio and AI industries on the global stage.”

Popular News